Cited by 1,690Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerChromatin Remodeling and Cancer

The DOI matches its Crossref record; 115 of the 122 references it cites were found in a registry or an index.

The RB and p53 pathways in cancer

Open access

Sherr, Charles J, McCormick, Frank·2002·Cancer Cell

Open this paper in CoChat — free account Open PDF

Abstract

The life history of cancer cells encompasses a series of genetic missteps in which normal cells are progressively transformed into tumor cells that invade surrounding tissues and become malignant. Most prominent among the regulators disrupted in cancer cells are two tumor suppressors, the retinoblastoma protein (RB) and the p53 transcription factor. Here, we discuss interconnecting signaling pathways controlled by RB and p53, attempting to explain their potentially universal involvement in the etiology of cancer. Pinpointing the various ways by which the functions of RB and p53 are subverted in individual tumors should provide a rational basis for developing more refined tumor-specific therapies.

Integrity signals

Registry

Crossref · 10.1016/s1535-6108(02)00102-2

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Self-citation
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“By inducing Arf and Ink4a in primary rodent fibroblasts, oncogenic Ras expression leads to growth arrest and premature senescence (Serrano et al., 1997; Ferbeyre et al., 2002).”
Background
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Untitled work
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585

Show all 122 references

Sorted by citations

Items 401–500 of 1,000

Post-translational modifications on the retinoblastoma protein
Zhou, L., Ng, D. S., Yam, J. C. S., Chen, L. J., Tham, C. C. Y., Pang, C. P., & Chu, W. K. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00818-x · Cited by 64
Models of ovarian cancer—Are we there yet?
Garson, K., Shaw, T. J., Clark, K., Yao, D., & Vanderhyden, B. C. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.03.019 · Cited by 63
Comparing Pearson, Spearman and Hoeffding’s D measure for gene expression association analysis
FUJITA, A., SATO, J. R., DEMASI, M. A. A., SOGAYAR, M. C., FERREIRA, C. E., & MIYANO, S. (2009) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720009004230 · Cited by 64
Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic Activity
Tan, J. Y., Zhuang, L., Jiang, X., Yang, K., Karuturi, K. M., & Yu, Q. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512719200 · Cited by 63
pRb Inactivation in Mammary Cells Reveals Common Mechanisms for Tumor Initiation and Progression in Divergent Epithelia
Simin, K. J., Wu, H., Lu, L., Pinkel, D., Albertson, D. G., Cardiff, R. D., & Dyke, T. V. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020022 · Cited by 62
Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells
Shimura, T., Ochiai, Y., Noma, N., Oikawa, T., Sano, Y., & Fukumoto, M. (2013) · Cell Cycle · doi:10.4161/cc.23719 · Cited by 64
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis
Opavský, R., Tsai, S., Guimond, M., Arora, A., Opavska, J., Becknell, B., Kaufmann, M. R., Walton, N. A., Stephens, J. A., Fernández, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706307104 · Cited by 63
Small tumor antigen of polyomaviruses: Role in viral life cycle and cell transformation
Khalili, K., Sariyer, I. K., & Safak, M. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21326 · Cited by 63
Inhibition of Cell Division by the Human Cytomegalovirus IE86 Protein: Role of the p53 Pathway or Cyclin-Dependent Kinase 1/Cyclin B1
Song, Y., & Stinski, M. F. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2597-2603.2005 · Cited by 63
Targeted cancer therapy with ribosome biogenesis inhibitors: a real possibility?
Brighenti, E., Treré, D., & Derenzini, M. (2015) · Oncotarget · doi:10.18632/oncotarget.5775 · Cited by 66
Artepillin C in Brazilian propolis induces G0/G1 arrest via stimulation of Cip1/p21 expression in human colon cancer cells
Shimizu, K., Das, S. K., Hashimoto, T., Sowa, Y., Yoshida, T., Sakai, T., Matsuura, Y., & Kanazawa, K. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20148 · Cited by 62
Abolition of Cyclin-Dependent Kinase Inhibitor p16 Ink4a and p21 Cip1/Waf1 Functions Permits Ras-Induced Anchorage-Independent Growth in Telomerase-Immortalized Human Fibroblasts
Wei, W., Jobling, W. A., Chen, W., Hahn, W. C., & Sedivy, J. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2859-2870.2003 · Cited by 68
The E2F1/Rb and p53/MDM2 Pathways in DNA Repair and Apoptosis: Understanding the Crosstalk to Develop Novel Strategies for Prostate Cancer Radiotherapy
Udayakumar, T. S., Shareef, M. M., Diaz, D. A., Ahmed, M. M., & Pollack, A. S. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.05.007 · Cited by 62
p16INK4a modulates p53 in primary human mammary epithelial cells.
Zhang, J., Pickering, C. R., Holst, C. R., Gauthier, M. L., & Tlsty, T. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1594 · Cited by 60
Adenoviral Vector-Based Strategies for Cancer Therapy
Sharma, A., Tandon, M., Bangari, D. S., & Mittal, S. K. (2009) · Current Drug Therapy · doi:10.2174/157488509788185123 · Cited by 60
Regulation of Cell Proliferation by Autocrine Motility Factor/Phosphoglucose Isomerase Signaling
Tsutsumi, S., Yanagawa, T., Shimura, T., Fukumori, T., Hogan, V. A., Kuwano, H., & Raz, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304537200 · Cited by 60
Functional gene expression analysis of clonal plasma cells identifies a unique molecular profile for light chain amyloidosis
Abraham, R. S., Ballman, K. V., Dispenzieri, A. A., Grill, D. E., Manske, M. K., Price-Troska, T. L., Gonzalez-Paz, N. C., Gertz, M. A., & Fonseca, R. (2004) · Blood · doi:10.1182/blood-2004-04-1424 · Cited by 60
Graded Levels of GATA-1 Expression Modulate Survival, Proliferation, and Differentiation of Erythroid Progenitors
Pan, X., Ohneda, O., Ohneda, K., Lindeboom, F., Iwata, F., Shimizu, R., Nagano, M., Suwabe, N., Philipsen, S., Lim, K.-C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500081200 · Cited by 60
The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells
Raza, S., Ohm, J. E., Dhasarathy, A., Schommer, J., Roche, C., Hammer, K. D. P., & Ghribi, O. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2551-7 · Cited by 61
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
Chen, D., Padiernos, E., Ding, F., Lossos, I. S., & Lopez, C. D. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401536 · Cited by 59
Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response
Maude, S. L., & Enders, G. H. (2005) · Cancer Research · doi:10.1158/0008-5472.780.65.3 · Cited by 58
The Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 62
Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin‐3 in gastric cancer cells
Endo, S., Yamato, K., Hirai, S., Moriwaki, T., Fukuda, K., Suzuki, H., Abei, M., Nakagawa, I., & Hyodo, I. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01821.x · Cited by 61
Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis
Cai, Y., Balli, D., Ustiyan, V., Fulford, L., Hiller, A., Misetic, V., Zhang, Y., Paluch, A. M., Waltz, S. E., Kasper, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455089 · Cited by 58
Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis
Cha, J. Y., Lambert, Q. T., Reuther, G. W., & Der, C. J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0187 · Cited by 61
Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells
Öztürk, N., Erdal, E., Mumcuoğlu, M., Akçalı, K. C., Yalcin-Ozuysal, Ö., Şentürk, Ş., Arslan-Ergül, A., Dedeoğlu, B. G., Yuluğ, I. G., Çetin-Atalay, R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510877103 · Cited by 60
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
Milewski, D., Balli, D., Ustiyan, V., Le, T. T., Dienemann, H., Warth, A., Breuhahn, K., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007097 · Cited by 60
Radiotherapy-Induced Senescence and its Effects on Responses to Treatment
Tabasso, A. F. S., Jones, D. J. L., Jones, G. D. D., & Macip, S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.003 · Cited by 60
Design, Synthesis, and Biological Evaluation of (E)-Styrylbenzylsulfones as Novel Anticancer Agents
Reddy, M. V. R., Mallireddigari, M. R., Cosenza, S. C., Pallela, V. R., Iqbal, N. M., Robell, K. A., Kang, A. D., & Reddy, E. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm701077b · Cited by 58
Cellular signaling in normal and cancerous stem cells
Grinstein, E., & Wernet, P. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.06.021 · Cited by 58
ALG-2: a Ca2+-binding modulator protein involved in cell proliferation and in cell death
Krebs, J. J. R., Saremaslani, P., & Caduff, R. F. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00446-6 · Cited by 58
Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel−/− B cells
Cheng, S., Hsia, C. Y., Leone, G. W., & Liou, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206917 · Cited by 58
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate
Scala, F., Brighenti, E., Govoni, M., Imbrogno, E., Fornari, F., Treré, D., Montanaro, L., & Derenzini, M. (2015) · Oncogene · doi:10.1038/onc.2015.147 · Cited by 59
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Boroujeni, A. M., Yousefi, E., Balakrishnan, R., Riviere, S., Kertowidjojo, E. C., Hensley, M. L., Ladanyi, M., Ellenson, L. H., & Chiang, S. (2023) · Modern Pathology · doi:10.1016/j.modpat.2022.100084 · Cited by 57
p300 is required for orderly G1/S transition in human cancer cells
Iyer, N. G., Xian, J., Chin, S.-F., Bannister, A. J., Daigo, Y., Aparicio, S. A. J. R., Kouzarides, T., & Caldas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209771 · Cited by 57
Basal-Like Breast Cancer: Update on Clinicopathologic, Immunohistochemical, and Molecular Features
Leidy, J., Khan, A. A., & Kandil, D. H. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0439-ra · Cited by 57
The Retinoblastoma Protein Is Required for Ras-Induced Oncogenic Transformation
Williams, J. P., Stewart, T. A., Li, B., Mulloy, R., Dimova, D. K., & Classon, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1170-1182.2006 · Cited by 57
A daunting task: manipulating leukocyte function with RNA i
Peer, D. (2013) · Immunological Reviews · doi:10.1111/imr.12044 · Cited by 57
A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells
Jin, F.-Z., Yu, C., Zhao, D., Wu, M., & Yang, Z. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.013 · Cited by 55
Epigenetic regulation of human retinoblastoma
Singh, U., Malik, M. A., Goswami, S., Shukla, S., & Kaur, J. (2016) · Tumor Biology · doi:10.1007/s13277-016-5308-3 · Cited by 58
Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma
Robinson, A. M., Rathore, R., Redlich, N. J., Adkins, D. R., VanArsdale, T. L., Tine, B. A. V., & Michel, L. S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2098-8 · Cited by 56
Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines
Deng, W., Tsao, S. W., Guan, X., Lucas, J. N., Hua, X., Leung, C. S., Mak, P. H. S., Wang, L., & Cheung, A. L. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208119 · Cited by 56
Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
Lee, H., Park, J., Forget, B., & Gaines, P. C. W. (2009) · Regenerative medicine · doi:10.2217/rme.09.46 · Cited by 56
IFI16 as a Negative Regulator in the Regulation of p53 and p21Waf1
Kwak, J. C., Ongusaha, P. P., Ouchi, T., & Lee, S. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308012200 · Cited by 56
Differential regulation of human YY1 and caspase 7 promoters by prohibitin through E2F1 and p53 binding sites
Joshi, B., Rastogi, S., Morris, M. D., Carastro, L. M., DeCook, C., Seto, E., & Chellappan, S. (2006) · Biochemical Journal · doi:10.1042/bj20060364 · Cited by 55
The naked mole-rat as an animal model in biomedical research: current perspectives
Smith, E. S. J., Schuhmacher, L.-N., & Husson, Z. (2015) · Open Access Animal Physiology · doi:10.2147/oaap.s50376 · Cited by 26
Induction and Validation of Cellular Senescence in Primary Human Cells
Hernandez‐Segura, A., Brandenburg, S. M., & Demaria, M. (2018) · Journal of Visualized Experiments · doi:10.3791/57782 · Cited by 64
Biochanin A Induces S Phase Arrest and Apoptosis in Lung Cancer Cells
Li, Y., Yu, H., Han, F., Wang, M., Luo, Y., & Guo, X. (2018) · BioMed Research International · doi:10.1155/2018/3545376 · Cited by 54
Antitumor protein therapy; Application of the protein transduction domain to the development of a protein drug for cancer treatment
Harada, H., Kizaka‐Kondoh, S., & Hiraoka, M. (2006) · Breast Cancer · doi:10.2325/jbcs.13.16 · Cited by 53
Treatment selection after imatinib resistance in chronic myeloid leukemia
Jabbour, E. J., Cortes, J. E., & Kantarjian, H. M. (2009) · Targeted Oncology · doi:10.1007/s11523-008-0100-y · Cited by 53
Regulation of tissue‐ and stimulus‐specific cell fate decisions by p53 in vivo
Jackson, J. G., Post, S. M., & Lozano, G. (2010) · The Journal of Pathology · doi:10.1002/path.2783 · Cited by 55
Genetic and Epigenetic Discoveries in Human Retinoblastoma
McEvoy, J. D., & Dyer, M. A. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2015013711 · Cited by 54
Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells
Benedict, B., van Harn, T., Dekker, M., Hermsen, S., Küçükosmanoğlu, A., Pieters, W., Delzenne‐Goette, E., Dorsman, J. C., Petermann, E., Foijer, F., et al. (2018) · eLife · doi:10.7554/elife.37868 · Cited by 54
MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
Bao, C., Chen, J., Chen, D., Lu, Y., Lou, W., Ding, B., Xu, L., & Fan, W. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02855-6 · Cited by 55
Induction of Cell Cycle Arrest in Prostate Cancer Cells by the Dietary Compound Isoliquiritigenin
Lee, Y. M., Lim, D. Y., Choi, H. J., Jung, J. I., Chung, W., & Park, J. H. Y. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0039 · Cited by 53
Hepatocyte Growth Factor Induces Redistribution of p21CIP1 and p27KIP1 through ERK-dependent p16INK4a Up-regulation, Leading to Cell Cycle Arrest at G1 in HepG2 Hepatoma Cells
Han, J., Tsukada, Y.-I., Hara, E., Kitamura, N., & Tanaka, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503431200 · Cited by 52
The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism
Santos, C. R., Vega, F. M. D. L., Blanco, S., Barcia, R., & Lazo, P. A. (2004) · Virology · doi:10.1016/j.virol.2004.08.013 · Cited by 52
RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene
Eguchi, T., Takaki, T., Itadani, H., & Kotani, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209810 · Cited by 54
Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer
Smolensky, D., Rathore, K., & Cekanova, M. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s112113 · Cited by 51
150th Anniversary Series: Desmosomes and the Hallmarks of Cancer
Huber, O., & Petersen, I. (2015) · Cell Communication & Adhesion · doi:10.3109/15419061.2015.1039642 · Cited by 54
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
Ingemarsdotter, C. K., Baird, S. K., Connell, C. M., Öberg, D., Halldén, G., & McNeish, I. A. (2010) · Oncogene · doi:10.1038/onc.2010.335 · Cited by 56
Regulation of p27 Kip1 by mitogen-induced tyrosine phosphorylation
Jäkel, H., Peschel, I., Kunze, C., Weinl, C., & Hengst, L. (2012) · Cell Cycle · doi:10.4161/cc.19957 · Cited by 52
Loss of Retinoblastoma Tumor Suppressor Protein Makes Human Breast Cancer Cells More Sensitive to Antimetabolite Exposure
Derenzini, M., Donati, G., Mazzini, G., Montanaro, L., Vici, M., Ceccarelli, C., Santini, D., Taffurelli, M., & Treré, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2065 · Cited by 50
The tumor suppressor role of CTCF
Fiorentino, F. P., & Giordano, A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22780 · Cited by 55
ATR-mediated proteome remodeling is a major determinant of homologous recombination capacity in cancer cells
Kim, D.-S., Liu, Y., Oberly, S., Freire, R., & Smolka, M. B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky625 · Cited by 53
Estradiol-17β-Induced Human Neural Progenitor Cell Proliferation Is Mediated by an Estrogen Receptor β-Phosphorylated Extracellularly Regulated Kinase Pathway
Wang, J. M., Liu, L., & Brinton, R. D. (2007) · Endocrinology · doi:10.1210/en.2007-1155 · Cited by 52
Maize reas1 Mutant Stimulates Ribosome Use Efficiency and Triggers Distinct Transcriptional and Translational Responses
Qi, W., Zhu, J., Wu, Q., Wang, Q., Li, X., Yao, D., Jin, Y., Wang, G., Wang, G., & Song, R. (2015) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.01722 · Cited by 50
Staging, Treatment, and Future Approaches of Gallbladder Carcinoma
Shukla, S. K., Singh, G., Shahi, K. S., Bhuvan, & Pant, P. (2017) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-017-0036-5 · Cited by 51
Activity of the Adenoviral E1A Deletion Mutant dl922-947 in Ovarian Cancer: Comparison with E1A Wild-type Viruses, Bioluminescence Monitoring, and Intraperitoneal Delivery in Icodextrin
Lockley, M., Fernández, M. G., Wang, Y., Li, N. F., Conroy, S. E., Lemoine, N. R., & McNeish, I. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2691 · Cited by 51
Plasminogen Activator Inhibitor-1 Suppresses Profibrotic Responses in Fibroblasts from Fibrotic Lungs
Marudamuthu, A. S., Shetty, S. K., Bhandary, Y. P., Karandashova, S., Thompson, M., Sathish, V., Florova, G., Hogan, T. B., Pabelick, C. M., Prakash, Y. S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601815 · Cited by 51
Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
Ng, K., Kim, R., Kesari, S., Carter, B. S., & Chen, C. C. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0714-2 · Cited by 50
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
Small molecule regulators of Rb–E2F pathway as modulators of transcription
Singh, S., Johnson, J. L., & Chellappan, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.004 · Cited by 51
Cyclin D2 Protein Stability Is Regulated in Pancreatic β-Cells
He, L. M., Sartori, D. J., Teta, M., Opare-Addo, L., Rankin, M. M., Long, S. Y., Diehl, J. A., & Kushner, J. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0057 · Cited by 49
The Genetic Signatures of Pediatric High-Grade Glioma: No Longer a One-Act Play
Diaz, A. K., & Baker, S. J. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2014.06.003 · Cited by 53
MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
Qi, D.-L., & Cobrinik, D. E. (2016) · Oncogene · doi:10.1038/onc.2016.350 · Cited by 51
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
Mei, J., Tian, H., Huang, H.-S., Hsu, C., Liou, Y., Wu, N., Zhang, W., & Chu, T. (2021) · Cell Proliferation · doi:10.1111/cpr.13029 · Cited by 50
Molecular Imaging: Reporter Gene Imaging
Serganova, I. S., Mayer-Kuckuk, P., Huang, R., & Blasberg, R. G. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-77496-9_8 · Cited by 50
Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines
von der Heyde, S., Bender, C., Henjes, F., Sonntag, J., Korf, U., & Beißbarth, T. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-75 · Cited by 50
Association of RB/p16-Pathway Perturbations with DCIS Recurrence
Witkiewicz, A. K., Rivadeneira, D. B., Ertel, A., Kline, J., Hyslop, T., Schwartz, G. F., Fortina, P. M., & Knudsen, E. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.043 · Cited by 50
Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer
Motadi, L. R., Bhoola, K. D., & Dlamini, Z. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.05.004 · Cited by 49
Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis
Leon, G. D., Sherry, T. C., & Krucher, N. A. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5839 · Cited by 48
Malignant transformation of canine oral papillomavirus (CPV1)-associated papillomas in dogs: An emerging concern?
Thaiwong, T., Sledge, D. G., Wise, A. G., Olstad, K. J., Maes, R. K., & Kiupel, M. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2018.10.007 · Cited by 49
Two-way traffic: centrosomes and the cell cycle
Sluder, G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1712 · Cited by 50
p16INK4a protects against dysfunctional telomere–induced ATR-dependent DNA damage responses
Wang, Y., Sharpless, N. E., & Chang, S. S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69574 · Cited by 49
Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer
Wilk, G., & Braun, R. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1250 · Cited by 47
p53-Autophagy-Metastasis Link
Denisenko, T. V., Pivnyuk, A. D., & Zhivotovsky, B. (2018) · Cancers · doi:10.3390/cancers10050148 · Cited by 51
CIB1 prevents nuclear GAPDH accumulation and non-apoptotic tumor cell death via AKT and ERK signaling
Leisner, T. M., Moran, C., Holly, S. P., & Parise, L. V. (2012) · Oncogene · doi:10.1038/onc.2012.408 · Cited by 46
The Fission Yeast Homeodomain Protein Yox1p Binds to MBF and Confines MBF-Dependent Cell-Cycle Transcription to G1-S via Negative Feedback
Aligianni, S., Lackner, D. H., Klier, S., Rustici, G., Wilhelm, B. T., Marguerat, S., Codlin, S., Brāzma, A., de Bruin, R. A. M., & Bähler, J. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000626 · Cited by 46
Dehydrocostuslactone Suppresses Angiogenesis In Vitro and In Vivo through Inhibition of Akt/GSK-3β and mTOR Signaling Pathways
Wang, C.-Y., Tsai, A.-C., Peng, C.-Y., Chang, Y.-L., Lee, K., Teng, C., & Pan, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031195 · Cited by 47
Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma
Michel, D. L., Chitanda, J. M., Balogh, R., Yang, P., Singh, J., Das, U., El‐Aneed, A., Dimmock, J. R., Verrall, R. E., & Badea, I. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.03.016 · Cited by 49
The retinoblastoma gene Rb and its family member p130 suppress lung adenocarcinoma induced by oncogenic K-Ras
Ho, V. M., Schaffer, B. E., Karnezis, A. N., Park, K. S., & Sage, J. (2009) · Oncogene · doi:10.1038/onc.2008.491 · Cited by 47
Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer
Knowles, L. M., & Smith, J. W. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-168 · Cited by 49
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death
Narayanan, K. B., Ali, M., Barclay, B. J., Cheng, Q. S., D'Abronzo, L. S., Dornetshuber-Fleiss, R., Ghosh, P., Guzman, M. J. G., Lee, T. J., Leung, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv032 · Cited by 50
Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901
Xing, C., Zhu, B.-S., Liu, H., Yao, H., & Zhang, L. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00393.x · Cited by 47
p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?
Li, N., Xie, C., & Lü, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11414 · Cited by 49
Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection
Gameiro, S. F., Zhang, A., Ghasemi, F., Barrett, J. W., Nichols, A. C., & Mymryk, J. S. (2017) · Viruses · doi:10.3390/v9090252 · Cited by 47
NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein
Waku, T., Nakamura, N., Koji, M., Watanabe, H., Katoh, H., Tatsumi, C., Tamura, N., Hatanaka, A., Hirose, S., Katayama, H., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00597-19 · Cited by 47
ERK activation is regulated by E2F1 and is essential for E2F1-induced S phase entry
Korotayev, K., Chaussepied, M., & Ginsberg, D. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.012 · Cited by 48
Replicative senescence promotes prothrombotic responses in endothelial cells: role of NADPH oxidase- and cyclooxygenase-derived oxidative stress
Silva, G. C., Abbas, M., Khemais-Benkhiat, S., Burban, M., Ribeiro, T. P., Toti, F., Idris-Khodja, N., Côrtes, S. F., & Schini-Kerth, V. B. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.04.006 · Cited by 44

Authors: Sherr, C. J., & McCormick, F.
Affiliations: St. Jude Children's Research Hospital (US)
University of California, San Francisco (US)
Corresponding author: Sherr, Charles J
ORCID: Sherr, Charles J
McCormick, Frank
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2002-08
Volume: 2
Issue: 2
Pages: 103-112
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/s1535-6108(02)00102-2
OpenAlex: W1992708996
Cited by: 1,690
References: 122
Citations by year: 2026: 31 · 2025: 40 · 2024: 36 · 2023: 60 · 2022: 56 · 2021: 62 · 2020: 62 · 2019: 67 · 2018: 75 · 2017: 67 · 2016: 60 · 2015: 71 · 2014: 88 · 2013: 81 · 2012: 90
FWCI: 7.67
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4003 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
Keywords: retinoblastoma protein, p53, tumor suppressor, malignant transformation, signaling pathways, cancer etiology, tumor-specific therapy, oncogenic transformation
MeSH terms: Cell Cycle, DNA-Binding Proteins, Humans, Neoplasms, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, Retinoblastoma Protein, Apoptosis, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The RB and p53 pathways in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks